CP-778875

N/A

Report date: 2025/04/24 16:17:26
NME

Base Information

Drug NameCP-778875
Drug Alias NameCP-778875
ClassificationSmall molecules
Mechanisms of ActionP-glycoprotein 1 inhibitorsBroad substrate specificity ATP-binding cassette transporter ABCG2 inhibitors
TargetsBroad substrate specificity ATP-binding cassette transporter ABCG2P-glycoprotein 1
Therapy Area/IndicationsDyslipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsDyslipidemias

Other Information

ATC CodeN/A
Related LinksN/A